This finding is consistent with the previous studies showing that WNT5A stimulates BMP-6 expression in metastatic prostate cancer (CaP) in the context of bone niche; and BMP-6 in turn stimulated the proliferation of CaP cells [33]. The gene discussed is BMP6; the disease is metastatic prostate carcinoma.